
Keytruda (pembrolizumab) and Rituxan (rituximab) showed promising results for patients with follicular lymphoma in a recent study.

Keytruda (pembrolizumab) and Rituxan (rituximab) showed promising results for patients with follicular lymphoma in a recent study.

A recent study found that women with breast cancer often have a network of people that they consult to help them make treatment decisions.

In an interview with CURE, Rami Komrokji, M.D., a hematologist at Moffitt Cancer Center in Tampa, Florida, discusses the advances that have been made in MDS in the past few years, as well as the MDS Clinical Research Consortium and its importance.

After cancer caught me off guard, I tend to wait for the other shoe to drop, even if that means getting scared when positive things come my way.

Scoring the big NED often leads to that "Terminator" voice whispering in your ear.

Chemotherapy-induced peripheral neuropathy affects many patients with cancer, so CURE spoke with an expert about coping strategies for those who have developed this condition.

CURE spoke with an expert on what is getting in the way of advancing treatment for rare types of ovarian cancer.

Yervoy (ipilimumab) was granted approval by the Food and Drug Administration (FDA) for the treatment of pediatric patients who are 12 years old or younger and have unresectable or metastatic melanoma, according to Bristol-Myers Squibb (BMS), the manufacturer of the CTLA-4 inhibitor.

There are a number of treatment methods being explored to treat glioblastoma.

Sexual intimacy is a subject that is difficult for many breast cancer survivors to discuss. The challenges of sexual intimacy are often created as a direct result of cancer treatments or can occur from the after effects which result in emotional scarring.

For people affected by cancer, the idea of starting fresh and with a clean slate is appealing. Here are a few of my favorite food trends.

Offering advice to others is usually helpful, but sometimes can end up being hurtful. As breast cancer veterans, do those of us who’ve been there tend to overshare?

Getting rid of my cancer clothes proves to be no easy task.

The immunotherapy agent Opdivo (nivolumab) showed clinical acitivty in women who had recurrent/metastatic cervical cancer, and was active to a lesser extent in vaginal and vulvar cancers, according to results from the CheckMate-358 trial.

Senator John McCain was diagnosed with an aggressive glioblastoma after going to the Mayo Clinic for a routine exam.

For years, the news has been full of stories about opioid addiction. I am just glad that painkillers that actually killed the pain were available when I needed them.

A breast cancer survivor looks at prescription drugs, and what we call them.

Ovarian cancer screening for women who do not have symptoms of the disease may do more harm than good, according to the USPSTF.

“If you locked everybody in a room for a week, I think we could come up with something that everybody would be comfortable with,” said Blase Polite, M.D., a co-author of the statement, and immediate past chair of ASCO’s government relations committee.

It's natural to feel overwhelmed with a cancer diagnosis. Grab back a little security by knowing what to expect

Being on blood thinner scares me.

Diagnosed with desmoplastic melanoma, sportscaster Holly Rowe is working with the Melanoma Research Foundation to teach about the disease.

CSC to release seminal research on the emotional, social, and financial burden on cancer patients


Patients with mantle cell lymphoma who were treated with Imbruvica had a better quality of life than those treated with another agent, according to the results of a recent study.

The doctor-patient relationship is a delicate one. It's one that needs to be comfortable between both parties. When and how do breast cancer patients know when it's time to make a change? This is an important decision that should not be taken lightly.

After a cancer diagnosis, it can feel as if your body has failed you. How do you go back to trusting it again?

Nerlynx (neratinib) was granted approval by the Food and Drug Administration (FDA) for the extended adjuvant treatment of patients with early stage, HER2-positive breast cancer who have already received postoperative Herceptin (trastuzumab).

An immunotherapy has become the first of its kind approved to treat Merkel cell carcinoma, a rare and still mysterious skin cancer.